Blockchain Registration Transaction Record

Personalized Vaccine Shows Promise Against Aggressive Brain Cancer

WashU Medicine's personalized vaccine shows promise in extending tumor-free survival for glioblastoma patients. Learn how this new treatment could revolutionize brain cancer care.

This news matters because glioblastoma is one of the most lethal brain cancers, with a median survival of only 12-15 months. A vaccine that extends tumor-free survival could offer new hope to patients and their families, potentially transforming the standard of care. The personalized approach also underscores the growing trend of tailored therapies in oncology, which may lead to more effective treatments with fewer side effects.